Metraipolis › archive › dc_183f55f4fc3c

Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA) — Europe PMC PMID:40965589

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40965589
DOI
10.1128/aac.00569-25
License (as archived)
solo-consultazione
Archived
2026-11-09T21:02:37.076Z
SHA-256 of the archived text
8782a3b54e75692f770247a9d3d55bad9e4e9d35038682a6c2d5543ed8631ad2
Stable URL of this page
https://metraipolis.com/documento/dc_183f55f4fc3c

How to cite

Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA) — Europe PMC PMID:40965589 — Europe PMC (en), https://europepmc.org/article/MED/40965589 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_183f55f4fc3c (Metraipolis archive dc_183f55f4fc3c, sha256 8782a3b54e75692f770247a9d3d55bad9e4e9d35038682a6c2d5543ed8631ad2)
BibTeX
@misc{dc183f55f4fc3c,
  title = {Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR Pseudomonas aeruginosa (PUMA) — Europe PMC PMID:40965589},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40965589},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_183f55f4fc3c; sha256 8782a3b54e75692f770247a9d3d55bad9e4e9d35038682a6c2d5543ed8631ad2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40965589. Agents can read the archived copy with the MCP tool read_document.